Role of fenofibrate alone and in combination with telmisartan on renal ischemiareperfusion injury

Renal Failure

Volumn 32, Issue 9, 2010, Pages 1088-1094

  Bhalodia, Yagnik ^a,b   Sheth, Navin ^c   Vaghasiya, Jitendra ^a,b   Jivani, Nurudin ^a,b  

^a SNDT Women's University   (India)

^b Jodhpur National University   (India)

^c SAURASHTRA UNIVERSITY   (India)

Author keywords

Acute renal failure; Angiotensin II; Homocysteine; Inflammation; Oxidative stress

Indexed keywords

BIOLOGICAL MARKER; CHOLESTEROL; CREATININE; FENOFIBRATE; GLUTATHIONE; HOMOCYSTEINE; MALONALDEHYDE; MYELOPEROXIDASE; NITRIC OXIDE; TELMISARTAN; UREA;

AMINO ACID BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL OCCLUSION; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL DIET; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DRUG EFFECT; DRUG MECHANISM; DRUG POTENTIATION; ENZYME ACTIVITY; HISTOPATHOLOGY; HYPERLIPIDEMIA; KIDNEY BLOOD VESSEL; KIDNEY ISCHEMIA; LIPID PEROXIDATION; MALE; MONOTHERAPY; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; RAT; RENAL PROTECTION; REPERFUSION INJURY; TREATMENT DURATION; UREA NITROGEN BLOOD LEVEL; WISTAR ALBINO GLAXO RAT;

ACUTE KIDNEY INJURY; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANIMALS; BENZIMIDAZOLES; BENZOATES; BIOLOGICAL MARKERS; DRUG THERAPY, COMBINATION; FENOFIBRATE; HOMOCYSTEINE; HYPOLIPIDEMIC AGENTS; KIDNEY; KIDNEY FUNCTION TESTS; MALE; OXIDATIVE STRESS; RATS; RATS, WISTAR; REPERFUSION INJURY;

EID: 77957282148     PISSN: 0886022X     EISSN: 15256049     Source Type: Journal    
DOI: 10.3109/0886022X.2010.504911     Document Type: Article

References (44)

1. Kumai T, Oonuma S, Kitaoka Y et al. Biochemical and morphological characterization of spontaneously hypertensive hyperlipidemic rats. Clin Exp Pharmacol Physiol. 2003;30:537-544. doi: 10.1046/j.1440-1681.2003.03872.x. (Pubitemid 37011591)
2. Bhalodia Y, Sheth N, Vaghasiya J, Jivani N. Hyperlipidemia enhanced oxidative stress and inflammatory response evoked by renal ischemia/reperfusion injury. Int J Pharmacol. 2010; 6(1):25-30.
3. Yellon DM, Baxter GF. Protecting the ischemic and reperfused myocardium in acute myocardial infarction: Distant dream or near reality? Heart. 2000;83:381-387. doi: 10.1136/heart.83.4.381.
4. Anja SM, Min WS, Kelly LH, et al. Hyperlipidemia aggravates renal disease in B6.ROP Os/+ mice. Kidney Int. 2004;66: 1393-1402. doi:10.1111/j.1523-1755. 2004.00854.x. (Pubitemid 39298371)
5. Edelstein CL, Ling H, Schrier RW. The nature of renal cell injury. Kidney Int. 1997;51:1341-1351. (Pubitemid 27239881)
6. Seujange Y, Eiam-Ong S, Tirawatnapong T, Eiam-Ong S. Role of angiotensin II on dihydrofolate reductase, GTPcyclohydrolase 1 and nitric oxide synthase expressions in renal ischemia-reperfusion. Am J Nephrol. 2008;28:692-700. (Pubitemid 351832458)
7. Park JK, Mervaala EM, Muller DN, et al. Rosuvastatin protects against angiotensin II-induced renal injury in a dosedependent fashion. J Hypertens. 2009;27:599-605.
8. Prathapasinghe GA, Siow YL, Karmin O. Detrimental role of homocysteine in renal ischemia-reperfusion injury. Am J Physiol Renal Physiol. 2007;292:1354-1363.
9. Toyama T, Nakamura H, Harano Y, et al. PPAR alpha ligands activate antioxidant enzymes and suppress hepatic fibrosis in rats. Biochem Biophys Res Commun. 2004;324:697-704. (Pubitemid 39345573)
10. Patel NS, di Paola R, Mazzon E, et al. Peroxisome proliferator- activated receptor-alpha contributes to the resolution of inflammation after renal ischemia/reperfusion injury. J Pharmacol Exp Ther. 2009;328:635-643.
11. Mandarim-de-Lacerda CA, Pereira LM. Effects of telmisartan on preexistent cardiac and renal lesions in spontaneously hypertensive mature rats. Histol Histopathol. 2004;19:727-733.
12. Tsunenari I, Ohmura T, Seidler R, et al. Renoprotective effects of telmisartan in the 5/6 nephrectomised rats. J Renin Angiotensin Aldosterone Syst. 2007;8:93-100. (Pubitemid 47272472)
13. Cibulskyte D, Pedersen M, Hørlyck A, et al. Telmisartan attenuates chronic ciclosporin A nephrotoxicity in a pig model. Nephrol Dial Transplant. 2007;22:369-375. (Pubitemid 46189879)
14. Benson SC, Pershadsingh HA, Ho C, et al. Identification of telmisartan as a unique angiotensin II receptor antagonist with selective PPAR-g modulating activity. Hypertension. 2004;43:993-1002. (Pubitemid 38579904)
15. Cianchetti S, Del Fiorentino A, Colognato R, Di Stefano R, Franzoni F, Pedrinelli R. Antiinflammatory and anti-oxidant properties of telmisartan in cultured human umbilical vein endothelial cells. Atherosclerosis. 2008;198:22-28. (Pubitemid 351406364)
16. Kakuta H, Sudoh K, Sasamatsu M, Yamagishi S. Telmisartan has the strongest binding affinity to angiotensin II type 1 receptor blockers. Int J Clin Pharm Res. 2005;25:41-46.
17. Bhalodia Y, Sheth N, Vaghasiya J, Jivani N. Cardiac damage induced by renal ischemia/reperfusion injury in hyperlipidemic rats: Role of PPAR-a agonist. Hong Kong J Nephrol. 2009;11(2):59-65.
18. Fouad AA, Qureshi HA, Ibrahim Al-Sultan A, Yacoubi MT, Al-Melhim WN. Nephroprotective effect of telmisartan in rats with ischemia/reperfusion renal injury. Pharmacology. 2010;85:158-167. doi: 10.1159/000269779.
19. Kumari CS, Govindasamy S, Sukumar E. Lipid lowering activity of Eclipta prostrate in experimental hyperlipidemia. J Ethnopharmacol. 2006;105:332-335. doi: 10.1016/j.jep.2005.10.031.
20. Kontogiannis J, Burns KD. Role of AT1 angiotensin II receptors in renal ischemic injury. Am J Physiol Renal Physiol. 1998; 274(43):79-90. (Pubitemid 28133976)
21. Slater TF, Sawyer BC. The stimulatory effects of carbon tetrachloride and other halogenoalkanes or peroxidative reactions in liver fractions in vitro. Biochem J. 1971; 123:805-814.
22. Moran MS, Depierre JW, Mannervik B. Levels of glutathione, glutathione reductase and glutathione S-transferase activities in rat lung and liver. Biochim Biophys Acta. 1979;582:567. doi: 10.1016/0304-4165(79):90289-7. (Pubitemid 9136111)
23. Guevara I, Iwanejko J, Dembinska-Kiec A. Determination of nitrite/nitrate in human biological material by the simple Griess reaction. Clin Chim Acta. 1998;274:177-188. doi: 10.1016/S0009-8981(98)00060-6. (Pubitemid 28269300)
24. Wei H, Frenkel K. Relationship of oxidative events and DNA oxidation in SENCAR mice to in vivo promoting activity of phorbol ester-type tumor promoters. Carcinogenesis. 1993;14:1195-1201. (Pubitemid 23193551)
25. Cau J, Favreau F, Zhang K, et al. FR167653 improves renal recovery and decreases inflammation and fibrosis after renal ischemia reperfusion injury. J Vasc Surg. 2009;49:728-740.
26. Korkmaz A, Kolankaya D. The protective effects of ascorbic acid against renal ischemia reperfusion injury in male rats. Ren Fail. 2009;31:36-43.
27. Volti GL, Sorrenti V, Murabito P, et al. Pharmacological induction of heme oxygenase-1 inhibits iNOS and oxidative stress in renal ischemia-reperfusion injury. Transplant Proc. 2007;39:2986-2991. (Pubitemid 350251511)
28. Cai H, Griendling KK, Harrison DG. The vascular NAD(P)H oxidases as therapeutic targets in cardiovascular diseases. Trends Pharmacol Sci. 2003;24:471-478. (Pubitemid 37088172)
29. Neto JS, Nakao A, Kimizuka K, et al. Protection of transplantinduced renal ischemia-reperfusion injury with carbon monoxide. Am J Physiol Renal Physiol. 2004;287:979-989. (Pubitemid 39391095)
30. Jia RP, Zhu JG, Wu JP, Xie JJ, Xu LW. Experimental study on early protective effect of ischemic preconditioning on rat kidney graft. Transplant Proc. 2009;41:69-72.
31. Salom MG, Cerón SN, Rodriguez F, et al. Heme oxygenase-1 induction improves ischemic renal failure: Role of nitric oxide and peroxynitrite. Am J Physiol Heart Circ Physiol. 2007;293: 3542-3549. (Pubitemid 350230898)
32. Guven A, Uysal B, Akgul O, et al. Scavenging of peroxynitrite reduces renal ischemia/reperfusion injury. Ren Fail. 2008; 30:747-754.
33. Yeh C-H, Chen T-P, Lee C-H, Wu Y-C, Lin Y-M, Lin PJ. Cardiomyocytic apoptosis following global cardiac ischemia and reperfusion can be attenuated by peroxisome proliferatory activated receptor a but not g activators. Shock. 2006;26(3):262-270. doi: 10.1097/01.shk.0000225863. 56714.96. (Pubitemid 44244960)
34. Hou X, Shen YH., Li C, Wang F, Zhang C, Bu P, Zhang Y. PPARa agonist fenofibrate protects the kidney from hypertensive injury in spontaneously hypertensive rats via inhibition of oxidative stress and MAPK activity. Biochem Biophys Res Commun. 2010;394(3):653-659. doi:10.1016/j.bbrc.2010.03.043.
35. Jung KH, Chu K, Lee ST, et al. Blockade of AT1 receptor reduces apoptosis, inflammation, and oxidative stress in normotensive rats with intracerebral hemorrhage. J Pharmacol Exp Ther. 2007;322:1051-1058. (Pubitemid 47295814)
36. Kobayashi N, Ohno T, Yoshida K, et al. Cardioprotective mechanism of telmisartan via PPAR-gamma-eNOS pathway in Dahl salt-sensitive hypertensive rats. Am J Hypertension. 2008;21:576-581. (Pubitemid 351589680)
37. Nakamura T, Keep RF, Hua Y, Hoff JT, Xi G. Oxidative DNA injury after experimental intracerebral hemorrhage. Brain Res. 2005;1039:30-36. (Pubitemid 40386824)
38. Blessing E, Preusch M, Kranzhöfer R, et al. Anti-atherosclerotic properties of telmisartan in advanced atherosclerotic lesions in apolipoprotein E deficient mice. Atherosclerosis. 2008;199:295-303.
39. Dimitropoulou C, Chatterjee A, McClud L, Tetik-Anacak G, Catravas JD. Angiotensin, bradykinin and the endothelium. In: Moncada S, Higgs A, eds. The Vascular Endothelium, Vol.I. Berlin: Springer; 2006:255-290.
40. Mehta PK, Griendling KK. Angiotensin II cell signalling: Physiological and pathological effects in the cardiovascular system. Am J Physiol Cell Physiol. 2007;292:82-97.
41. Prathapasinghe GA, Siow YL, Xu Z, Karmin O. Inhibition of cystathionine-b-synthase activity during renal ischemiareperfusion: Role of pH and nitric oxide. Am J Physiol Renal Physiol. 2008;295:912-922.
42. Dierkes J, Westphal S, Luley S. Serum homocysteine increases after therapy with fenofibrate or bezafibrate. Lancet. 1999; 354:219-220. (Pubitemid 29329164)
43. Auwerx J, Schoonjans K, Fruchart JC, Staels B. Transcriptional control of triglyceride metabolism: Fibrates and fatty acids change the expression LPL and apoC-III genes by activating the nuclear receptor PPAR. Atherosclerosis. 1996; 124:29-37. (Pubitemid 26268443)
44. Fruchart JC, Duriez P, Staels B. Peroxisome proliferatoractivated receptor-a activators regulate genes governing lipoprotein metabolism, vascular inflammation and atherosclerosis. Curr Opin Lipidol. 1999;10:245-257. (Pubitemid 29405915)